NYSE:WST

West Pharmaceutical Services Short Interest Ratio and Short Volume

$316.79
+2.96 (+0.94 %)
(As of 04/19/2021 12:00 AM ET)
Add
Compare
Today's Range
$311.77
Now: $316.79
$317.19
50-Day Range
$257.29
MA: $282.36
$313.83
52-Week Range
$163.79
Now: $316.79
$317.19
Volume334,371 shs
Average Volume465,698 shs
Market Capitalization$23.39 billion
P/E Ratio83.59
Dividend Yield0.22%
Beta1.13

Short Interest

West Pharmaceutical Services (NYSE:WST) Short Interest Data

Current Short Volume692,500 shares
Previous Short Volume643,800 shares
Change Vs. Previous Month:+7.56%
Dollar Volume Sold Short$205.63 million
Short Interest Ratio / Days to Cover1.5
Last Record DateMarch, 31 2021
Outstanding Shares73,750,000 shares
Float Size73,350,000 shares
Short Percent of Float0.94%
Today's Trading Volume334,371 shares
Average Trading Volume465,698 shares
Today's Volume Vs. Average-28.20%

Short Interest Over Time


West Pharmaceutical Services (NYSE:WST) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/2021692,500 shares $205.63 million +7.6%0.9%1.5 $296.94
3/15/2021643,800 shares $180.46 million +6.9%0.9%1.3 $280.31
2/26/2021602,000 shares $161.17 million -9.9%0.8%1.2 $267.73
2/12/2021668,400 shares $187.59 million -21.0%0.9%1.4 $280.65
1/29/2021845,500 shares $247.13 million +20.9%1.2%1.8 $292.29
1/15/2021699,100 shares $208.97 million +6.2%1.0%1.6 $298.92
12/31/2020590,000 shares $178.42 million +7.6%0.8%1.4 $302.41
12/15/2020590,000 shares $171.70 million +7.6%0.8%1.4 $291.02
11/30/2020548,600 shares $152.32 million -8.3%0.8%1.2 $277.66
10/30/2020626,900 shares $182.41 million -17.3%0.9%1.4 $290.97
10/15/2020758,000 shares $216.84 million +10.9%1.0%1.6 $286.07
9/30/2020683,600 shares $204.72 million -3.6%0.9%1.3 $299.48
9/15/2020709,100 shares $191.11 million -4.6%1.0%1.3 $269.51
8/31/2020743,600 shares $205.33 million +0.9%1.0%1.3 $276.13
8/14/2020736,700 shares $207.57 million +5.5%1.0%1.2 $281.75
7/31/2020698,100 shares $192.12 million -9.2%1.0%0.8 $275.20
7/15/2020768,700 shares $206.68 million -16.0%1.1%0.9 $268.87
6/30/2020915,500 shares $240.47 million +0.2%1.3%1.1 $262.66
6/15/2020914,100 shares $206.49 million +30.3%1.3%1.1 $225.89
5/29/2020701,500 shares $151.88 million -3.4%1.0%0.8 $216.51
5/15/2020725,900 shares $156.82 million -8.2%1.0%0.9 $216.04
4/30/2020791,000 shares $159.22 million +2.3%1.1%1.5 $201.29
4/15/2020773,400 shares $162.61 million -2.0%1.1%1.5 $210.25
3/31/2020789,400 shares $154.36 million -27.3%1.1%1.5 $195.54
3/13/20201,086,300 shares $176.99 million +8.6%1.5%2.7 $162.93

West Pharmaceutical Services (NYSE:WST) Short Interest FAQ

speech bubbles
speech bubbles











What is West Pharmaceutical Services' current short interest?

Short interest is the volume of West Pharmaceutical Services shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 692,500 shares of WST short. 0.94% of West Pharmaceutical Services' shares are currently sold short. View details.

What is a good short interest ratio for West Pharmaceutical Services?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. West Pharmaceutical Services currently has a short interest ratio of 2.0.

What is a good short interest percentage for West Pharmaceutical Services?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.94% of West Pharmaceutical Services' floating shares are currently sold short.

Is West Pharmaceutical Services' short interest increasing or decreasing?

West Pharmaceutical Services saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 692,500 shares, an increase of 7.6% from the previous total of 643,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is West Pharmaceutical Services' float size?

West Pharmaceutical Services currently has issued a total of 73,850,000 shares. Some of West Pharmaceutical Services' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. West Pharmaceutical Services currently has a public float of 73,350,000 shares.

How does West Pharmaceutical Services' short interest compare to its competitors?

0.94% of West Pharmaceutical Services' shares are currently sold short. Here is how the short interest of companies in the sub-industry of "health care supplies" compare to West Pharmaceutical Services: Align Technology, Inc. (2.39%), The Cooper Companies, Inc. (2.58%), DENTSPLY SIRONA Inc. (1.15%), STAAR Surgical (0.00%), Quidel Co. (10.89%), Neogen Co. (0.00%), ICU Medical, Inc. (2.16%), Haemonetics Co. (3.13%), Merit Medical Systems, Inc. (4.39%), and Atrion Co. (4.69%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Analog Devices, Inc. ($5.84 billion), Aon plc ($5.47 billion), Charter Communications, Inc. ($5.36 billion), ViacomCBS Inc. ($3.99 billion), Snap Inc. ($3.77 billion), Airbnb, Inc. ($2.90 billion), Peloton Interactive, Inc. ($2.43 billion), Discovery, Inc. ($2.38 billion), The Kroger Co. ($2.28 billion), and Expedia Group, Inc. ($2.18 billion). View all of the most shorted stocks.

What does it mean to sell short West Pharmaceutical Services stock?

Short selling WST is an investing strategy that aims to generate trading profit from West Pharmaceutical Services as its price is falling. West Pharmaceutical Services' stock is trading up $2.96 today. To short West Pharmaceutical Services stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that West Pharmaceutical Services will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against West Pharmaceutical Services?

A short squeeze for West Pharmaceutical Services occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of WST, which in turn drives the price of the stock up even further.

How often is West Pharmaceutical Services' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including WST, twice per month. The most recent reporting period available is March, 31 2021.



This page was last updated on 4/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.